Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
ESC 2020
Pharma
Merck's Steglatro shows limited promise with heart failure data
Merck & Co.'s Steglatro cut heart failure patients' total hospitalization in a limited subanalysis from a noninferiority study against placebo.
Kyle Blankenship
Aug 31, 2020 3:00am
AZ's Farxiga scores big trial win in chronic kidney disease
Aug 30, 2020 11:00am
Novartis' Entresto scores mixed win in heart failure study
Aug 30, 2020 10:30am
Pfizer, BMS' Eliquis cuts site-specific bleeds over rivals
Aug 29, 2020 11:16am
Amgen chases pediatric use for cholesterol-buster Repatha
Aug 29, 2020 5:20am
Amarin's Vascepa reduces coronary plaque at the 18-month mark
Aug 29, 2020 3:13am
